Generic Egrifta

At least one patent currently prevents generic Egrifta from being manufactured. The earliest this situation could change is in May 2015, when the patent is scheduled to expire. However, other patents or lawsuits could shorten or lengthen this period. Tesamorelin is the active ingredient in this product and is often referred to as the "generic name"; this is not the same as a "generic version."

Can I Buy Generic Egrifta?

Egrifta™ (tesamorelin acetate) is a prescription medication used to decrease unwanted stomach fat deposits in people with lipodystrophy related to medications used to treat human immunodeficiency virus (HIV).
 
Egrifta is made by EMD Serono, Inc., U.S. At this time, there are no generic versions.
 

When Will Generic Egrifta Be Available?

The first patent for Egrifta currently expires in May 2015. This is the earliest predictable date that a generic version could become available.
 
However, other circumstances could come up to extend or shorten this exclusivity period. This could include such things as lawsuits or other patents for specific Egrifta uses. Once the patent expires, there may be several companies that manufacture a generic Egrifta drug.
 

Is Tesamorelin a Generic Egrifta?

No -- tesamorelin is the active ingredient in Egrifta, but is not a generic version of it. What can be confusing is that oftentimes, the active ingredient of a drug is referred to as the "generic name." The generic name is different from a generic version of a medicine.
 
In order for there to be a generic version of a medicine, the original medicine must have gone off-patent and another company besides the original manufacturer must make the product.
 

Egrifta Medication Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.